Scholars@Duke

Systemically administrered EGRFvIII-targeted bispecific antibody as an immunotherapeutic for glioblastoma.

Fellowship Grant
Duke Scholars
Charles Gersbach
Collaborator Charles Gersbach Biomedical Engineering
Michael Rod Zalutsky
Collaborator Michael Rod Zalutsky Radiology
John Howard Sampson
Principal Investigator John Howard Sampson Neurosurgery
Kent James Weinhold
Collaborator Kent James Weinhold Surgery, Surgical Sciences
Mark Wesley Dewhirst
Collaborator Mark Wesley Dewhirst Radiation Oncology
Chien-Tsun Kuan
Collaborator Chien-Tsun Kuan Pathology
James Emmett Herndon II
Collaborator James Emmett Herndon II Biostatistics & Bioinformatics, Division of Biostatistics
Bruce Kendall Burnett
Collaborator Bruce Kendall Burnett Medicine, Clinical Pharmacology
Darell Doty Bigner
Collaborator Darell Doty Bigner Neurosurgery

Administered By

Neurosurgery

Awarded By

National Institutes of Health

Start Date

March 1, 2015

End Date

February 28, 2019
 

Administered By

Neurosurgery

Awarded By

National Institutes of Health

Start Date

March 1, 2015

End Date

February 28, 2019